SI2277546T1 - Stabilen pripravljen za uporabo injekcijski sestavek paracetamola - Google Patents
Stabilen pripravljen za uporabo injekcijski sestavek paracetamolaInfo
- Publication number
- SI2277546T1 SI2277546T1 SI200931237T SI200931237T SI2277546T1 SI 2277546 T1 SI2277546 T1 SI 2277546T1 SI 200931237 T SI200931237 T SI 200931237T SI 200931237 T SI200931237 T SI 200931237T SI 2277546 T1 SI2277546 T1 SI 2277546T1
- Authority
- SI
- Slovenia
- Prior art keywords
- use injectable
- stable ready
- paracetamol formulation
- injectable paracetamol
- formulation
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09009569.6A EP2277546B1 (en) | 2009-07-23 | 2009-07-23 | Stable ready to use injectable paracetamol formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2277546T1 true SI2277546T1 (sl) | 2015-09-30 |
Family
ID=41264251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200931237T SI2277546T1 (sl) | 2009-07-23 | 2009-07-23 | Stabilen pripravljen za uporabo injekcijski sestavek paracetamola |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2277546B1 (sl) |
CY (1) | CY1116746T1 (sl) |
DK (1) | DK2277546T3 (sl) |
ES (1) | ES2545484T3 (sl) |
HK (1) | HK1153400A1 (sl) |
HR (1) | HRP20150815T1 (sl) |
HU (1) | HUE027032T2 (sl) |
PL (1) | PL2277546T3 (sl) |
PT (1) | PT2277546E (sl) |
SI (1) | SI2277546T1 (sl) |
SM (1) | SMT201500192B (sl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2414557B1 (es) | 2012-01-16 | 2014-06-10 | Novocat Farma, S.A. | Composición acuosa de paracetamol para inyección |
ZA201300398B (en) * | 2012-11-27 | 2013-09-25 | Genfarma Laboratories S L | Injectable liquid formulation of the combination of tramadol and paracetamol |
CN116869983A (zh) * | 2016-09-16 | 2023-10-13 | 锡德克斯药物公司 | 包含对乙酰氨基酚和磺烷基醚环糊精的制剂 |
GR1010637B (el) * | 2023-01-13 | 2024-02-15 | Ιουλια Κλεωνος Τσετη | Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
FR2751875B1 (fr) | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
EA006939B1 (ru) * | 2001-12-18 | 2006-06-30 | Юни-Фарма Клеон Цетис Фармасьютикал Лэборетериз С. А. | Парентеральная композиция парацетамола |
CN1232539C (zh) * | 2002-05-10 | 2005-12-21 | 刘云清 | 有机药物与倍他环糊精衍生物的配合物及其制备方法 |
EP2056850A4 (en) * | 2006-08-08 | 2011-10-12 | Univ Louisiana State | THERAPEUTIC METHODS FOR TREATING NEUROPATHIC PAIN |
US9399012B2 (en) * | 2007-11-13 | 2016-07-26 | Mallinckrodt Ip | Reduced dose intravenous acetaminophen |
-
2009
- 2009-07-23 SI SI200931237T patent/SI2277546T1/sl unknown
- 2009-07-23 PT PT90095696T patent/PT2277546E/pt unknown
- 2009-07-23 ES ES09009569.6T patent/ES2545484T3/es active Active
- 2009-07-23 PL PL09009569T patent/PL2277546T3/pl unknown
- 2009-07-23 EP EP09009569.6A patent/EP2277546B1/en active Active
- 2009-07-23 DK DK09009569.6T patent/DK2277546T3/en active
- 2009-07-23 HU HUE09009569A patent/HUE027032T2/en unknown
-
2011
- 2011-07-22 HK HK11107648.8A patent/HK1153400A1/xx not_active IP Right Cessation
-
2015
- 2015-07-27 HR HRP20150815TT patent/HRP20150815T1/hr unknown
- 2015-08-06 SM SM201500192T patent/SMT201500192B/xx unknown
- 2015-08-21 CY CY20151100733T patent/CY1116746T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SMT201500192B (it) | 2015-09-07 |
ES2545484T3 (es) | 2015-09-11 |
PT2277546E (pt) | 2015-09-25 |
HK1153400A1 (en) | 2012-03-30 |
CY1116746T1 (el) | 2017-03-15 |
DK2277546T3 (en) | 2015-08-17 |
PL2277546T3 (pl) | 2015-10-30 |
EP2277546B1 (en) | 2015-07-15 |
HUE027032T2 (en) | 2016-08-29 |
HRP20150815T1 (hr) | 2015-09-11 |
EP2277546A1 (en) | 2011-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2616064T (pt) | Formulações de cetorolac prontas para utilização | |
DK2387989T3 (da) | Langtidsvirkende formuleringer med insuliner | |
EP2646468A4 (en) | ANTI-NGF COMPOSITIONS AND THEIR USE | |
EP2718317A4 (en) | GLUCOSE-DEPENDENT INSULINOTROPE POLYPEPTIDE ANALOGUE, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | |
GB201010193D0 (en) | Medicinal use | |
ZA201208726B (en) | High-temperature stable oxygen-carrier-containing pharmaceutical composition | |
IL221857A (en) | Liquid formulations are stabilized | |
HK1182315A1 (en) | Stable ready to use injectable paracetamol formulation | |
EP2599484A4 (en) | INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE | |
IL239049A0 (en) | Dimeric compounds containing oxazolidinone, preparations, methods for their preparation and their use | |
AU332760S (en) | Spatula head | |
EP2576612A4 (en) | INSULIN ANALOG | |
EP2620160A4 (en) | COMPOSITIONS FOR ORAL ADMINISTRATION | |
PL2521445T3 (pl) | Preparat i jego zastosowanie | |
GB201003218D0 (en) | Improvements relating to platform devices | |
HK1153400A1 (en) | Stable ready to use injectable paracetamol formulation | |
IL222277A0 (en) | Pharmaceutical compositions highly dosed with biotin | |
IL206739A0 (en) | Injectable pharmaceutical composition | |
HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
EP2536688A4 (en) | STABLE DOSAGE FORMS OF LEVOMILNACIPRAN | |
ZA201300098B (en) | Pharmaceutical composition with enhanced solubility characteristics | |
GB201010242D0 (en) | Single use disposable feet protectors with advertising purpose for external use | |
ZA200808734B (en) | Injectable liquid paracetamol formulation | |
IL208677A0 (en) | Spatula | |
PL393180A1 (pl) | Preparat weterynaryjny |